Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: Pooled analysis of the ONO-4538-05 and ONO-4538-06 studies
- Hideo Saka
- , Makoto Nishio
- , Toyoaki Hida
- , Kazuhiko Nakagawa
- , Hiroshi Sakai
- , Naoyuki Nogami
- , Shinji Atagi
- , Toshiaki Takahashi
- , Hidehito Horinouchi
- , Mitsuhiro Takenoyama
- , Nobuyuki Katakami
- , Hiroshi Tanaka
- , Koji Takeda
- , Miyako Satouchi
- , Hiroshi Isobe
- , Makoto Maemondo
- , Koichi Goto
- , Tomonori Hirashima
- , Koichi Minato
- , Nobumichi Yada
Research output: Contribution to journal › Article › peer-review
11
Link opens in a new tab
Citations
(Scopus)